The morbidity and mortality of stroke may be lowered considerably by instituting preventive interventions for patients at risk. A number of important clinical trials have compared the use of novel agents (dabigatran, rivaroxaban, and apixaban) with standard anticoagulant therapy to prevent stroke and ...
Stroke is a medical condition that occurs due to uninterrupted blood supply to the brain and when the blood supply to part of your brain is interrupted or reduced, preventing brain tissue from getting oxygen and nutrients. It is considered as the second
The role of neurologists in the treatment of older patients with epilepsy Epilepsy is a common disease in the elderly. About 1.5% of elderly individuals are thought to suffer from epilepsy; however, the medical system is insuffic... T Tanaka - 《Neurological Therapeutics》 被引量: 0发表: 202...
Coordinated multidisciplinary efforts by cardiologists, primary care physicians, and neurologists may be needed to meet the increasing challenge of stroke prevention and rhythm management in AF. This article discusses the potential the role of the cardiologist in the management of stroke prevention in ...
of care is on the COVID-19 patients, we quickly understood we needed to provide our stroke programme site leaders with alternative workflows and resources to be able to continue to provide stroke care to patients presenting with stroke during the surge. Because of the magnitude of impact that ...
Only in a small percentage of patients, the treatment results in complete regression of neurologic deficit. After stroke, patients must learn to live with an arrey of restrictions in various fields of life, which is frequently quite difficult to accomplish. In many of them, the disease and its...
Stroke is the second leading cause of death worldwide; however, the treatment choices available to neurologists are limited in clinical practice. Lipocalin 2 (LCN2) is a secreted protein, belonging to the lipocalin superfamily, with multiple biological functions in mediating innate immune response, ...
This neurodegeneration has a recognizable presentation, which can be apparent to the trained neurologist allowed consistent follow-up. Yet there is no molecular or biochemical test of peripheral tissues, which means that cases can only be confirmed at postmortem by the loss of dopaminergic neurons in...
MS is more common in women at 20–50 years [7]. Of note, MS was initially identified by Jean-Martin Charcot, a French neurologist, in 1868, who described multiple scars in the brain and spinal cord [8]. To better understand the MS pathophysiology, we focused on the lipids that play ...
American Heart Association: 2004 heart and stroke statistical update. Available at http://www.Americanheart.Org/statistics/index.html. Accessed November 2004. Sanossian N, Ovbiagele B: Multimodality stroke prevention. Neurologist 2006, 12:14–31. Article PubMed Google Scholar Cholesterol, diastolic...